Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline Augmentation in Pediatric OCD
NCT01695291Phase 2Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- May 2012
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of minocycline in obsessive compulsive disorder (OCD), sponsored by New York State Psychiatric Institute. Started May 2012; status: completed.
02
Drugs
minocycline
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on NCT01695291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01695291.